https://www.onclive.com/view/dr-schetelig-on-the-use-of-induction-chemotherapy-prior-to-allo-hct-in-relapsed-refractory-aml
0
0
9/21/23 at 2:14pm
Organization
OncLive
47 words
0
Comments
Johannes Schetelig, MD, MSc, discusses whether patients with active relapsed/refractory acute myeloid leukemia (AML) should receive remission induction chemotherapy prior to undergoing allogenic hematopoietic stem cell transplant (allo-HCT).
You are the first to view
Create an account
or login to join the discussion